Intellectual Property Week 2 Nptel Assignment Answers 2025

Are you looking for Intellectual Property Week 2 Nptel Assignment Answers 2025 ? You’ve come to the right place! Access the most accurate answers at Progiez.



Course Link: Click Here

Intellectual Property Week 2 Nptel Assignment Answers 2025 (Jan-Apr 2025)


1. The turnover of a startup should not exceed

  • 25 crores within the 5 years period
  • 100 crores within the 10 years period
  • 20 crores within the 5 years period
  • 20 crores within the 7 years period

View Answer


2. Novartis patent was for-

  • Beta crystalline form of Imatinib Mesylate.
  • Alpha crystalline form of Imatinib Mesylate.
  • Gamma crystalline form of Imatinib Mesylate.
  • None of the above

View Answer


3. The ability of mass duplication in intangible assets exists because of the trait:

  • Sunkenness
  • Scalability
  • Liquidity
  • None of the above

View Answer


4. Definition of start-Up is in

  • Rule 2 f(b)
  • Rule 4 a
  • Rule 20
  • Rule 16

View Answer


5. Statement 1: An entity shall cease to be a startup on completion of 7 years from the date of its incorporation/registration.
Statement 2: In respect of Startups in the biotechnology sector, an entity shall cease to be a Startup on completion of 7 years from the date of its incorporation/registration.

  • Statement 1 is True and Statement 2 is False
  • Statement 1 is False and Statement 2 is True
  • Both Statement 1 and 2 are True
  • Both Statement 1 and 2 are False

View Answer


6. Statement 1: “Synergies” in intangibility refers to the fact that the benefit of an intangible asset may accrue on others.
Statement 2: Strong IP rights increase investment and reduce synergies and leads to Patent thickets.

  • Statement 1 is True and Statement 2 is False
  • Statement 1 is False and Statement 2 is True
  • Both Statement 1 and 2 are True
  • Both Statement 1 and 2 are False
See also  Intellectual Property Week 1 Nptel Assignment Answers 2025

View Answer


7. The ground pertaining to the rejection of the Novartis patent is:

  • Not an invention under section 3(d)
  • Non-disclosure of biological material
  • No-Prior art found
  • Lack of inventive step

View Answer


8. FRAND license term includes:

  • Fair and Reasonable terms
  • Non-discriminatory
  • Limitation of technology usage
  • None of the above

View Answer


9. Which of the following falls under intangible investments?

  • New technological ideas
  • New Product designs
  • New Business Models
  • Ownership of land as asset

View Answer


10. The Novartis standard established after the judgment is/are:

  • Identifying the new form of the known substance
  • Comparing the pharmacological properties of the known substance with new form of the known substance
  • Provide comparative material on enhanced efficacy
  • Lack of inventive step

View Answer


Intellectual Property Week 2 Nptel Assignment Answers 2025

For answers to others Nptel courses, please refer to this link: NPTEL Assignment